{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:32:48Z","timestamp":1787754768238,"version":"build-2784847793"},"reference-count":25,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1136\/ijgc-2023-005217","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T01:57:08Z","timestamp":1717120628000},"page":"1389-1398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["How deep is too deep? Assessing myometrial invasion as a predictor of distant recurrence in stage I endometrioid endometrial cancer"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6007-7323","authenticated-orcid":false,"given":"Giorgia","family":"Dinoi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5840-699X","authenticated-orcid":false,"given":"Simone","family":"Garzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"McGree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9413-316X","authenticated-orcid":false,"given":"Gretchen","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9361-8392","authenticated-orcid":false,"given":"Carrie","family":"Langstraat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1470-1305","authenticated-orcid":false,"given":"Amanika","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Weroha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison E","family":"Garda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Shahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6566-2502","authenticated-orcid":false,"given":"Emilia","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2758-1063","authenticated-orcid":false,"given":"Giovanni","family":"SCAMBIA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Fanfani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8059-1602","authenticated-orcid":false,"given":"Andrea","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2023-005217_bb0010","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1136\/ijgc-2023-005217_bb0015","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1136\/ijgc-2021-002668","article-title":"Response to: are we confident treating Pt1A G1 lymphovascular space invasion-negative patients (with myometrial invasion) with chemoradiotherapy on the basis of P53Abn?","volume":"31","author":"Concin","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-005217_bb0020","doi-asserted-by":"crossref","first-page":"vi33","DOI":"10.1093\/annonc\/mdt353","article-title":"Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Colombo","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2023-005217_bb0025","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1200\/JCO.18.01575","article-title":"Phase III trial: adjuvant pelvic radiation therapy versus vaginal brachytherapy plus paclitaxel\/carboplatin in high-intermediate and high-risk early stage endometrial cancer","volume":"37","author":"Randall","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2023-005217_bb0030","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC study group. Post operative radiation therapy in endometrial carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2023-005217_bb0035","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.ejca.2010.06.002","article-title":"Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies","volume":"46","author":"Hogberg","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2023-005217_bb0040","first-page":"287","article-title":"New gynecologic cancer staging","volume":"75","author":"Creasman","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2023-005217_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9378(51)91086-1","article-title":"A clinicopathological classification of endometrial carcinoma based on physical findings, anatomical extent, and histological grade","volume":"62","author":"FINN","year":"1951","journal-title":"Am J Obstet Gynecol"},{"key":"10.1136\/ijgc-2023-005217_bb0050","first-page":"825","article-title":"Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study","volume":"63","author":"Boronow","year":"1984","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2023-005217_bb0055","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0002-9378(85)90371-0","article-title":"Risk factors and recurrent patterns in stage I endometrial cancer","volume":"151","author":"DiSaia","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"10.1136\/ijgc-2023-005217_bb0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0090-8258(91)90086-K","article-title":"Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a gynecologic oncology group study","volume":"40","author":"Morrow","year":"1991","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-005217_bb0065","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/cncr.10660","article-title":"The significance of the amount of myometrial invasion in patients with stage IB endometrial carcinoma","volume":"95","author":"Alektiar","year":"2002","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2023-005217_bb0070","first-page":"336","article-title":"The significance of the degree of myometrial invasion in patients with stage IB endometrial cancer","volume":"25","author":"Gemer","year":"2004","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1136\/ijgc-2023-005217_bb0075","first-page":"1715","article-title":"Lymph-vascular space involvement and outer one-third myometrial invasion are strong predictors of distant haematogeneous failures in patients with stage I-II endometrioid-type endometrial cancer","volume":"29","author":"Gadducci","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1136\/ijgc-2023-005217_bb0080","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1006\/gyno.2002.6836","article-title":"Surgical stage I endometrial cancer: predictors of distant failure and death","volume":"87","author":"Mariani","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-005217_bb0085","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejogrb.2023.05.001","article-title":"Tumor free distance from serosa and survival rates of endometrial cancer patients: a meta-analysis","volume":"286","author":"Pergialiotis","year":"2023","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1136\/ijgc-2023-005217_bb0090","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/ijgc-2020-002094","article-title":"Adjuvant chemotherapy in early-stage endometrioid endometrial cancer with >50% myometrial invasion and negative lymph nodes","volume":"31","author":"Multinu","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-005217_bb0095","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2023-005217_bb0100","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S1470-2045(19)30395-X","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial","volume":"20","author":"de Boer","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1136\/ijgc-2023-005217_bb0105","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1097\/IGC.0000000000000490","article-title":"Lymphovascular space invasion portends poor prognosis in low-risk endometrial cancer","volume":"25","author":"dos Reis","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-005217_bb0110","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/IGC.0000000000001229","article-title":"Prognostic significance of lymphovascular space invasion in the absence of lymph node metastases in early-stage endometrial cancer","volume":"28","author":"Cusano","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-005217_bb0115","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/ijgc-2018-000069","article-title":"Prognostic significance of lymphovascular space invasion in low-risk endometrial cancer","volume":"29","author":"Ayhan","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-005217_bb0120","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.ejca.2015.05.015","article-title":"Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--a pooled analysis of PORTEC 1 and 2 trials","volume":"51","author":"Bosse","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2023-005217_bb0125","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2023-005217_bb0130","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ygyno.2021.05.029","article-title":"Prognostic value of myometrial invasion and TCGA groups of endometrial carcinoma","volume":"162","author":"Raffone","year":"2021","journal-title":"Gynecol Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24035448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24035448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2023-005217","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T01:54:44Z","timestamp":1756691684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24035448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1048891X24035448"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2023-005217","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How deep is too deep? Assessing myometrial invasion as a predictor of distant recurrence in stage I endometrioid endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2023-005217","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}